Apyx Medical (APYX) Operating Leases (2019 - 2026)

Apyx Medical has reported Operating Leases for 8 years, with the latest figure at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 10.51% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (down 10.51% YoY), and the FY2025 full-year result was $4.1 million, down 9.64% from the prior year.
• Operating Leases for Q1 2026 stood at $3.9 million, down from $4.1 million in the prior quarter.
• The five-year high for Operating Leases was $5.3 million in Q3 2023, with the low at $448000.0 in Q1 2023.
• Historically, Operating Leases has averaged $3.6 million across 5 years, with a median of $4.3 million in 2025.
• Annual changes were most pronounced in 2022 — Operating Leases surged 2213.33% — and 2024, when it declined 13.13%.
• Apyx Medical's Operating Leases stood at $470000.0 in 2022, then soared by 941.7% to $4.9 million in 2023, then fell by 8.44% to $4.5 million in 2024, then slipped by 9.64% to $4.1 million in 2025, then dropped by 3.09% to $3.9 million in 2026.
• The last three Operating Leases figures came in at $3.9 million (Q1 2026), $4.1 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.